Find your path to Pablo
1,150 people in our graph share verified history with Pablo — schools, employers, funds. One of them is your warm intro.
About
Pablo Villoslada is a neurologist with more than 20 years of experience in translational medicine across academia, biotech, medical devices, and pharmaceutical settings, currently serving as Head of the Department of Neurology at Hospital del Mar–Parc de Salut MAR. His work spans drug development for neurological diseases, including preclinical and clinical phases and regulatory filings with the FDA and EMA, as well as medical devices, neurostimulation, imaging, and applications of machine learning in health. He has founded and advised several biotech and medtech companies in the fields of central nervous system disorders and ophthalmology, including Bionure/Accure, QMenta, SpiralTx, Attune Neurosciences, CLight, Adhera Health, and NeuroPrex.
CSO at Accure
Intro paths
In turn, Pablo can intro founders to Accure's investors below.
Accure's investors · 3
Experience
- Hospital del Mar- Parc de Salut MARHead, Department of Neurologycurrent2023 — presentBarcellona
- Universitat Pompeu FabraAdjunct Professorcurrent2019 — presentBarcelona
- Adhera HealthMedical Advisorcurrent2021 — presentPalo Alto, California, United States
- Attune NeurosciencesFounder and advisor2019 — 2024Palo Alto
- Accure TherapeuticsTranslational Medicine2019 — 2023
- Biomimetic Sciences InstituteScientific Advisor2020 — 2023Barcelona, Catalonia, Spain
- Stanford UniversityAdjunct Professor2018 — 2023Palo Alto
- Alta Life SciencesVenture Partner2018 — 2021Palo Alto
- QMENTA IncChief Medical Officer2015 — 2020Greater Boston Area
- Health EngineeringChief Medical Officer2015 — 2020Bilbao Area, Spain
- Spiral TherapeuticsScientific Advisor - Medical Development2017 — 2019San Francisco Bay Area
- SPIRE BioventuresPartner2014 — 2019
- GenentechMedical Director Clinical Development Neuroinflammation2017 — 2018San Francisco, CA, US
- Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)Group leader Pathogenesis and new therapies for Multiple Sclerosis2008 — 2017
- UCSFAdjunct Professor2014 — 2017UCSF Sandler Center. 2nd Floor. room 3206 675 Nelson Rising Ln San Francisco CA
- BionureChief Scientific Officer2009 — 2016
- Clínica Universidad de NavarraDirector Multiple Sclerosis Center2001 — 2008
- Hospital Universitari Vall d'HebronClinical Fellow1998 — 1999
- UCSFPostdoctoral Fellow1996 — 1997
- Hospital Universitari Vall d'HebronResident Neurology1992 — 1995
Skills & more
+2 more
Medical ImagingArtificial Intelligence (AI)Languages English · Spanish
From Pablo's professional profile.
Frequently asked questions
- Who is Pablo Villoslada?
- Pablo Villoslada is a neurologist with more than 20 years of experience in translational medicine across academia, biotech, medical devices, and pharmaceutical settings, currently serving as Head of the Department of Neurology at Hospital del Mar–Parc de Salut MAR. His work spans drug development for neurological diseases, including preclinical and clinical phases and regulatory filings with the FDA and EMA, as well as medical devices, neurostimulation, imaging, and applications of machine learning in health. He has founded and advised several biotech and medtech companies in the fields of central nervous system disorders and ophthalmology, including Bionure/Accure, QMenta, SpiralTx, Attune Neurosciences, CLight, Adhera Health, and NeuroPrex.
- Where does Pablo Villoslada work?
- Pablo Villoslada is CSO at Accure.
- Where did Pablo Villoslada go to school?
- Pablo Villoslada studied at Universidad de Santiago de Compostela (MD, Medicina).
Same school
Also attended Universidad de Santiago de Compostela13
+ 7 more
Shared employers
Also worked at Hospital del Mar- Parc de Salut MAR1
Also worked at Stanford University1,146
+ 1,140 more
